If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOptiBiotix Health Share News (OPTI)

Share Price Information for OptiBiotix Health (OPTI)

Share Price is delayed by 15 minutes
Get Live Data
6.35    -0.10 (-1.55%)
Bid:
6.30
Ask:
6.40
Spread: 0.10 (1.587%)
Market Cap: £6.56m
OPTI Live PriceLast checked at - London Stock Exchange

Intraday OptiBiotix Health Share Chart

OptiBiotix launches range into large Indian chemist chain

Tue, 20th Sep 2022 11:37

(Sharecast News) - OptiBiotix Health announced on Tuesday that its subsidiary OptiBiotix Ltd launched its 'GoFigure' range with Apollo Hospitals & Pharmacies on 18 September.

The AIM-traded firm described Apollo Pharmacies as "the largest and most trusted" branded pharmacy network with 5,000 outlets across India.

It said GoFigure is its direct-to-consumer range of weight management products, combining various meal replacement, "healthy snacking" and powdered beverage products containing its weight management ingredient 'SlimBiome'.

"We are very pleased that our GoFigure products are now available to the consumer in India through Apollo Pharmacies, a leading pharmacy chain in India," said OptiBiotix Ltd chief executive officer René Kamminga.

"Our GoFigure range of weight management products have been specifically formulated to support consumers on a weight loss journey by reducing hunger and food cravings as well as modifying the gut microbiome in the direction of a lean person.

"This launch is another important step in building sales and brand presence for OptiBiotix's solutions with major partners around the world."

At 1127 BST, shares in OptiBiotix Health were down 0.99% at 17.08p.

Reporting by Josh White at Sharecast.com.

Related News

EARNINGS & TRADING: Microsalt lowers sales 2026 guidance
28 May 2026

EARNINGS & TRADING: Microsalt lowers sales 2026 guidance

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Thursday and not separately repor...

OptiBiotix reports higher revenue, improved margins
28 May 2026

OptiBiotix reports higher revenue, improved margins

(Sharecast News) - OptiBiotix Health reported higher annual revenue and improved margins for 2025 on Thursday, as the life sciences group said it was ...

WINNERS & LOSERS: Hamak jumps on gold data; MicroSalt cuts sales guide
28 May 2026

WINNERS & LOSERS: Hamak jumps on gold data; MicroSalt cuts sales guide

(Alliance News) - The following are the leading risers and fallers among London Main Market small-cap and AIM stocks on Thursday.

OptiBiotix Health News

EARNINGS & TRADING: Microsalt lowers sales 2026 guidance
28 May 2026

EARNINGS & TRADING: Microsalt lowers sales 2026 guidance

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Thursday and not separately repor...

OptiBiotix reports higher revenue, improved margins
28 May 2026

OptiBiotix reports higher revenue, improved margins

(Sharecast News) - OptiBiotix Health reported higher annual revenue and improved margins for 2025 on Thursday, as the life sciences group said it was ...

WINNERS & LOSERS: Hamak jumps on gold data; MicroSalt cuts sales guide
28 May 2026

WINNERS & LOSERS: Hamak jumps on gold data; MicroSalt cuts sales guide

(Alliance News) - The following are the leading risers and fallers among London Main Market small-cap and AIM stocks on Thursday.

WINNERS & LOSERS: Auction upgrades guidance; Aquila talks break down
14 May 2026

WINNERS & LOSERS: Auction upgrades guidance; Aquila talks break down

(Alliance News) - The following are the leading risers and fallers among London Main Market small-cap and AIM stocks on Thursday.

TRADING UPDATES: OptiBiotix Health hails 2025 revenue surge
1 Apr 2026

TRADING UPDATES: OptiBiotix Health hails 2025 revenue surge

(Alliance News) - The following is a round-up of trading updates by London-listed companies, issued on Wednesday and not separately reported by Allian...

Optibiomix begins NHS trial on Wellbiome's effect on cardiac surgeries
24 Feb 2026

Optibiomix begins NHS trial on Wellbiome's effect on cardiac surgeries

(Alliance News) - Optibiotix Health PLC on Tuesday said it began a clinical trial to determine the effect of its Wellbiome fibre complex on cardiac su...

OptiBiotix launches WellBiome study with Hull NHS trust
24 Feb 2026

OptiBiotix launches WellBiome study with Hull NHS trust

(Sharecast News) - OptiBiotix Health announced the start of a clinical study with Hull University Teaching Hospitals NHS Trust on Tuesday, to assess w...

IN BRIEF: SkinBioTherapeutics board member to oversee external probe
20 Feb 2026

IN BRIEF: SkinBioTherapeutics board member to oversee external probe

SkinBioTherapeutics PLC - Newcastle Upon Tyne, England-based life sciences - Non-Executive Director Alyson Levett will oversee an independent investi...